Act II Global Acquisition Corp. (ACTTU), filed their 8-a12b yesterday and is getting ready to price their $250 million “Better-for-you” focused SPAC tonight. Act II most recently dropped J.P. Morgan as its lead underwriter giving Cantor the chance to sole book-run. It’s a strong look for Cantor, but I doubt J.P. Morgan is hand-wringing. JPM is currently #2 in Bloomberg’s US Equity Offerings League Tables year-to-date so this is a minor blip for them.
Having said that, SPACs are a pretty particular product and it’s not that surprising that a team would want an experienced SPAC underwriter to lead and Cantor has certainly been a profilic player in the space. Stay tuned for any surprise up-sizes or changes to terms.
Summary of terms below:
News and Rumors CNBC: Former WeWork (OTC Pink:WEWKQ) founder Adam Neumann has offered to buy back control of the company for $500 million but has yet to secure the necessary financing. WeWork went public with BowX in October 2021. PR: Satellite telecom firm Spire Global (NYSE:SPIR) has signed an agreement to build and launch two...
Bannix (NASDAQ:BNIX) has entered into a definitive agreement to combine with VisionWave Technologies for $30 million. The combined company is expected to trade on the Nasdaq once the deal is completed with an initial outside date of September 14. Transaction Overview Bannix has about $17 million in its trust after seeing 77.4% of its shares...
At the SPAC of Dawn Much of the attention yesterday was on tracking the swings of the newly-completed Trump Media (NASDAQ:DJT) deal with the FT going as far to suggest it may “make SPACs great again.” Not all of the day’s data points were on the positive side of the ledger, however. IB Acquisition Corp....
News and Rumors SpaceNews: Boeing (NYSE:BA) has sued Virgin Galactic (NASDAQ:SPCE) alleging the space tourism venture refused to pay $25 million it owed for design work and violated Boeing’s intellectual property rights. Virgin Galactic combined with Social Capital Hedosophia in 2019. Bloomberg: The most popular options contract for Trump Media (NASDAQ:DJT) predicts it to plunge...
APx (NASDAQ:APXI) has entered into a definitive agreement to combine with precision medicine firms OmnigenicsAI and MultiplAI at an enterprise value $340 million. Once combined, these companies will offer DNA tests to consumers linked to predictive insights on their nutritional and genomic health. The combined company is expected to trade on the Nasdaq under the...